Cipla Limited - Asset Resilience Ratio

Latest as of September 2025: 20.75%

Cipla Limited (CIPLA) has an Asset Resilience Ratio of 20.75% as of September 2025. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing. Read debt load of Cipla Limited for a breakdown of total debt and financial obligations.

Liquid Assets

Rs83.35 Billion

≈ $901.43 Million USD Cash + Short-term Investments

Total Assets

Rs401.64 Billion

≈ $4.34 Billion USD All company assets

Resilience Assessment

Good

Financial Resilience Level

Asset Resilience Ratio Trend (2004–2025)

This chart shows how Cipla Limited's Asset Resilience Ratio has changed over time. See Cipla Limited (CIPLA) net assets for net asset value and shareholders' equity analysis.

Liquid Assets Composition Over Time

This chart breaks down Cipla Limited's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time. For market capitalisation and broader financial context, see CIPLA stock market capitalisation.

Current Liquid Assets Breakdown

Component	Amount	% of Total Assets
Cash & Equivalents	Rs7.96 Billion	1.98%
Short-term Investments	Rs75.39 Billion	18.77%
Total Liquid Assets	Rs83.35 Billion	20.75%

Asset Resilience Insights

Good Liquidity Position: Cipla Limited maintains a healthy 20.75% of assets in liquid form.
This level provides good financial flexibility while maintaining productive asset deployment.
The company has significant short-term investments, indicating active treasury management.

Cipla Limited Industry Peers by Asset Resilience Ratio

Compare Cipla Limited's asset resilience ratio with other companies in the same industry.

Company	Industry	Asset Resilience Ratio
Takeda Pharmaceutical Co Ltd ADR NYSE:TAK	Drug Manufacturers - Specialty & Generic	4.94%
Regencell Bioscience Holdings Ltd NASDAQ:RGC	Drug Manufacturers - Specialty & Generic	43.05%
Changchun High & New Technology Industries Group Inc SHE:000661	Drug Manufacturers - Specialty & Generic	3.73%
Yuhan Corp. KO:000100	Drug Manufacturers - Specialty & Generic	0.99%
Tonghua Dongbao Pharmaceutical Co Ltd SHG:600867	Drug Manufacturers - Specialty & Generic	1.96%
Shandong Buchang Pharmaceuticals Co Ltd SHG:603858	Drug Manufacturers - Specialty & Generic	3.47%
Guangdong Zhongsheng Pharmaceutical Co Ltd SHE:002317	Drug Manufacturers - Specialty & Generic	6.62%
Guobang Pharma Ltd SHG:605507	Drug Manufacturers - Specialty & Generic	8.47%

Annual Asset Resilience Ratio for Cipla Limited (2004–2025)

The table below shows the annual Asset Resilience Ratio data for Cipla Limited.

Year	Asset Resilience Ratio (%)	Liquid Assets	Total Assets	Change
2025-03-31	26.83%	Rs100.32 Billion ≈ $1.08 Billion	Rs373.87 Billion ≈ $4.04 Billion	+4.93pp
2024-03-31	21.90%	Rs71.65 Billion ≈ $774.91 Million	Rs327.18 Billion ≈ $3.54 Billion	+2.49pp
2023-03-31	19.41%	Rs57.19 Billion ≈ $618.51 Million	Rs294.63 Billion ≈ $3.19 Billion	+4.58pp
2022-03-31	14.83%	Rs40.19 Billion ≈ $434.67 Million	Rs271.01 Billion ≈ $2.93 Billion	+2.49pp
2021-03-31	12.34%	Rs31.03 Billion ≈ $335.55 Million	Rs251.52 Billion ≈ $2.72 Billion	+10.48pp
2020-03-31	1.86%	Rs4.39 Billion ≈ $47.52 Million	Rs236.63 Billion ≈ $2.56 Billion	+1.32pp
2019-03-31	0.53%	Rs1.28 Billion ≈ $13.86 Million	Rs239.63 Billion ≈ $2.59 Billion	-0.07pp
2018-03-31	0.61%	Rs1.39 Billion ≈ $15.05 Million	Rs228.61 Billion ≈ $2.47 Billion	+0.55pp
2017-03-31	0.06%	Rs118.30 Million ≈ $1.28 Million	Rs210.37 Billion ≈ $2.28 Billion	-2.71pp
2016-03-31	2.77%	Rs5.85 Billion ≈ $63.26 Million	Rs211.28 Billion ≈ $2.28 Billion	+0.29pp
2015-03-31	2.48%	Rs3.90 Billion ≈ $42.18 Million	Rs157.18 Billion ≈ $1.70 Billion	-0.43pp
2014-03-31	2.91%	Rs3.90 Billion ≈ $42.18 Million	Rs134.03 Billion ≈ $1.45 Billion	-15.25pp
2013-03-31	18.16%	Rs21.17 Billion ≈ $228.92 Million	Rs116.59 Billion ≈ $1.26 Billion	+8.10pp
2012-03-31	10.06%	Rs9.41 Billion ≈ $101.71 Million	Rs93.50 Billion ≈ $1.01 Billion	+7.46pp
2011-03-31	2.60%	Rs2.24 Billion ≈ $24.18 Million	Rs85.97 Billion ≈ $929.70 Million	+2.59pp
2010-03-31	0.01%	Rs5.20 Million ≈ $56.24K	Rs73.09 Billion ≈ $790.45 Million	-13.04pp
2009-03-31	13.05%	Rs8.95 Billion ≈ $96.78 Million	Rs68.57 Billion ≈ $741.53 Million	-6.20pp
2008-03-31	19.25%	Rs11.03 Billion ≈ $119.33 Million	Rs57.33 Billion ≈ $619.96 Million	+4.05pp
2007-03-31	15.20%	Rs6.71 Billion ≈ $72.56 Million	Rs44.14 Billion ≈ $477.33 Million	+3.59pp
2006-03-31	11.61%	Rs4.01 Billion ≈ $43.42 Million	Rs34.58 Billion ≈ $374.01 Million	-3.36pp
2005-03-31	14.97%	Rs3.91 Billion ≈ $42.28 Million	Rs26.12 Billion ≈ $282.50 Million	-0.43pp
2004-03-31	15.40%	Rs3.42 Billion ≈ $36.98 Million	Rs22.20 Billion ≈ $240.10 Million	--

pp = percentage points

About Cipla Limited

NSE:CIPLA India Drug Manufacturers - Specialty & Generic

Market Cap

$11.44 Billion

Rs1.06 Trillion INR

Market Cap Rank

#2017 Global

#79 in India

Share Price

Rs1309.60

Change (1 day)

-0.61%

52-Week Range

Rs1192.40 - Rs1663.60

All Time High

Rs1683.00